# Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/targeted-combination-therapies-in-oncology-challenging-regulatory-frameworks/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julie M. Vancoppenolle,Simone N. Koole,James F. O’Mahony,Nora Franzen,Jacobus A. Burgers,Valesca P. Retèl,Willem H. van Harten |
| Citations | 6 |
| DOI | 10.1016/j.drudis.2023.103620 |
| Fields | Economics, Econometrics and Finance,Immunology and Microbiology |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.drudis.2023.103620 |
| OpenAlex ID | https://openalex.org/W4377042548 |
| PMID | 37201780 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Nora Franzen](https://scholariq.org/researchers/nora-franzen/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.